Live Breaking News & Updates on Institutional Trading Of Fusion Pharmaceuticals

Stay updated with breaking news from Institutional trading of fusion pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Fusion Pharmaceuticals (NASDAQ:FUSN) Sees Large Volume Increase

Fusion Pharmaceuticals (NASDAQ:FUSN) Sees Large Volume Increase
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United-states , Canada , Wellington , New-zealand-general , New-zealand , Raymond-james , Nasdaq , Jennison-associates , News-ratings-for-fusion-pharmaceuticals-daily , Wellington-management-group , Institutional-trading-of-fusion-pharmaceuticals , Fusion-pharmaceuticals-inc

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Given Consensus Recommendation of "Hold" by Brokerages

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Given Consensus Recommendation of "Hold" by Brokerages
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

China , New-york , United-states , Canada , Raymond-james , Nasdaq , Fusion-pharmaceuticals-stock-performance , York-state-common-retirement-fund , Tower-research-capital , China-universal-asset-management-co , Fusion-pharmaceuticals-company-profile , News-ratings-for-fusion-pharmaceuticals-daily

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Short Interest Down 8.3% in March

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report) saw a large decline in short interest during the month of March. As of March 15th, there was short interest totalling 7,920,000 shares, a decline of 8.3% from the February 29th total of 8,640,000 shares. Based on an average daily volume of 2,210,000 shares, the short-interest ratio […] ....

Canada , United-states , Leerink-partnrs , William-blair , News-ratings-for-fusion-pharmaceuticals-daily , Fusion-pharmaceuticals-stock-performance , Millennium-management , Renaissance-technologies , Institutional-trading-of-fusion-pharmaceuticals , Fusion-pharmaceuticals , Schonfeld-strategic-advisors , Fusion-pharmaceuticals-inc

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Receives Consensus Recommendation of "Hold" from Brokerages

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Receives Consensus Recommendation of "Hold" from Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada , United-states , Leerink-partnrs , Raymond-james , Nasdaq , Perceptive-advisors , Hermes-inc , Fusion-pharmaceuticals-price-performance , Fusion-pharmaceuticals , Sphera-funds-management , Analyst-recommendations-for-fusion-pharmaceuticals , Fusion-pharmaceuticals-inc

Fusion Pharmaceuticals (NASDAQ:FUSN) Reaches New 12-Month High at $21.32

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report)’s stock price hit a new 52-week high on Monday . The company traded as high as $21.32 and last traded at $21.29, with a volume of 225039 shares traded. The stock had previously closed at $21.24. Analysts Set New Price Targets Several brokerages have issued reports on […] ....

Canada , United-states , Fusion-pharmaceuticals-inc , News-ratings-for-fusion-pharmaceuticals-daily , Institutional-trading-of-fusion-pharmaceuticals , Fusion-pharmaceuticals-stock , Fusion-pharmaceuticals-company-profile , Renaissance-technologies , Royal-bank , Nasdaq , Tower-research-capital